The Maryland House of Delegates has approved a bill that would allow terminally ill adults to obtain prescription drugs to end their lives. The vote was 74-66, three votes more than the 71 votes required for passage. A companion bill is pending in the state Senate.
After failing in past years, a bill to permit terminally ill Maryland residents to obtain prescription drugs to end their own lives is moving forward in the state's General Assembly. Two House of Delegates committees jointly voted to advance the “End of Life Option Act" to the full chamber.
The U.S. Supreme Court has declined to review a federal court's decision that struck down a unique Maryland law to curb price gouging for generic prescription drugs. The General Assembly passed the law in 2017 at the urging of state Attorney General Brian Frosh and health care advocates.
On Saturday morning, more than 90,000 prescription drug home disposal pouches will begin their journey from Aberdeen Proving Ground for distribution across Maryland, as Maryland National Guard troops load out pallets of the pouches for transport.
Doctors have made progress in recent years to reduce the prescription of methadone to fight pain amid efforts to reduce use of the drug after a spate of overdose deaths, a study by The Pew Charitable Trusts found.
bs-ed-op-0222-drug-commission. In the absence of action at the federal level to address rising drug costs, Maryland has taken the lead on this critical issue. This year, we’ve introduced legislation to create a Drug Cost Commission that would set fair rates for high cost drugs in Maryland.
Carroll commissioners last week asked its legal staff to look into whether it would be wise for the county to join many others in Central Maryland and file a lawsuit against the pharmaceutical companies that manufacture and marketed prescription opioid drugs. Our only question is what took so long?
Paragon Bioservices, a Baltimore-based contract drug maker, said Tuesday that it would expand with a new manufacturing facility for gene therapies near BWI Marshall Airport that will employ more than 200 people.
Vitreon America Inc. will move its headquarters to Baltimore City from Northern Virginia, bringing 200 full-time jobs over five years and a 200,000-square-foot high-tech laboratory, company and state officials announced Monday
Emocha Mobile Health, a Baltimore-based health technology startup, is expanding its mobile application that helps people takes their medications as prescribed to opioid addiction treatment with a $1.7 million federal grant and $1 million in private funding.
Cerecor, a Baltimore pharmaceutical development firm that went public in October 2015, has been notified that its stock no longer qualifies for listing on the Nasdaq market because it's been trading under $1 a share for 30 days.
As the Maryland House considers drug pricing transparency measures, it's important to remember that the bills being put forth are a crucial first step, a legislative floor not ceiling, for building a movement to ensure accountability in government spending and most importantly to ensuring the most vulnerable among us are guaranteed access to life-saving medications. It's the least we can do for our community.
Maryland's biopharmaceutical industry welcomes an honest dialogue about the cost of our total health care system and how we can work together to lower those costs. Unfortunately, the drug transparency legislation under consideration in Annapolis will do nothing to promote this dialogue, nor will it help patients or payers better understand their true drug costs. It will serve only to add more risk to our already risky business model and dampen the incentives that make it attractive to invest in
We cannot have an honest discussion about curtailing health care costs without looking at the double and even triple-digit increases in some of the most commonly prescribed medications. Higher prescription-drug spending increases costs for taxpayer-funded programs such as Medicare and Medicaid. This translates into higher taxes, cuts to public programs or both. This month, policymakers in Annapolis introduced a series of bills to help make sure that prescription drugs more affordable for
One of the nation's largest pharmaceutical distributors has agreed to pay $44 million to resolve allegations that it did not report suspicious orders of prescription painkillers such as oxycodone from pharmacies in Maryland, Florida, New York